TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION, 0.25% 2.5 mg/mL Solution/ Drops
Coverage in Nevada (CMS PDP Region 29).
10 of 10 stand-alone Part D plans in Nevada cover this drug on tier 3–4.
No plan applies a prior authorization, step therapy or quantity limit.
Alternatives: compare Glaucoma eye drops side by side on every plan in Nevada.
Every plan that covers it
See timolol on one plan, with the monthly patient cost → or compare all Glaucoma eye drops on a plan
Showing 10 of 10 plans
| Plan | Tier | 30-day preferred | 90-day mail | Unit cost | Est. 30-day fill | Restrictions |
|---|---|---|---|---|---|---|
| Humana Basic Rx Plan (PDP)$0.00/mo premium · $615.00 deductible · $0 with full Extra Help | 4Non-Preferred Drug | 32% | — | $47.8551 | — | None |
| Wellcare Classic (PDP)$2.70/mo premium · $615.00 deductible · $0 with full Extra Help | 4Non-Preferred Drug | 31% | 31% | $29.7476 | — | None |
| Wellcare Value Script (PDP)$2.70/mo premium · $615.00 deductible | 4Non-Preferred Drug | 40% | 40% | $29.7476 | — | None |
| Humana Value Rx Plan (PDP)$43.70/mo premium · $601.00 deductible | 4Non-Preferred Drug | 34% | — | $48.5998 | — | None |
| HealthSpring Extra Rx (PDP)$52.60/mo premium · $615.00 deductible | 4Non-Preferred Drug | 30% | 30% | $17.4212 | — | None |
| AARP Medicare Rx Saver from UHC (PDP)$76.70/mo premium · $615.00 deductible | 4Non-Preferred Drug | 34% | — | $31.0397 | — | None |
| HealthSpring Assurance Rx (PDP)$95.60/mo premium · $615.00 deductible | 4Non-Preferred Drug | 30% | 30% | $16.3816 | — | None |
| SilverScript Choice (PDP)$97.40/mo premium · $615.00 deductible | 4Non-Preferred Drug | 33% | 33% | $30.7360 | — | None |
| AARP Medicare Rx Preferred from UHC (PDP)$139.10/mo premium · $130.00 deductible | 3Preferred Brand | 18% | 18% | $33.8007 | — | None |
| Humana Premier Rx Plan (PDP)$148.70/mo premium · $0.00 deductible | 4Non-Preferred Drug | 50% | 50% | $47.6851 | — | None |
Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.
What it costs through the year
- Negotiated price per unit
- $16.38–$48.60
- across 10 plans; median $30.74
- 1. Deductible. Until you have met your plan’s deductible ($0.00–$615.00 on the plans covering it), you pay the plan’s full negotiated price. Some plans exempt lower tiers from the deductible; the plan page says which.
- 2. Initial coverage. You pay the plan’s copay or coinsurance: 18%, 30%, 31%, 32%, 33%, 34% of the negotiated price.
- 3. Catastrophic coverage. Once your out-of-pocket spending for the year reaches $2,100.00, you pay $0 for covered drugs for the rest of 2026.
Work out your 2026 costs month by month in the PDP-Planner →
Prices are each plan’s negotiated price from the CMS 2026 prescription drug plan pricing file, which a pharmacy may differ from slightly. On every plan, a covered insulin costs no more than $35 a month and the deductible does not apply to it.
Medicare Advantage plans
Medicare Advantage plans carry their own formularies, separate from stand-alone Part D, and are sold county by county. Pick a county to see every Medicare Advantage drug plan there that covers this drug.
87 Medicare Advantage plans in NV do cover it
A patient on an MA-PD plan may have coverage even where no PDP lists the drug. NV: 87 plans.